US 7999077
IRTA2 antibodies and methods of use
granted A61KA61K2039/505A61P
Quick answer
US patent 7999077 (IRTA2 antibodies and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/02